This synergistic peptide blend pairs Ipamorelin, a selective growth hormone secretagogue, with CJC-1295 (without DAC), a potent GHRH analog. Together, they are widely researched for their ability to stimulate pulsatile growth hormone release and support studies focused on cellular recovery, metabolism, and tissue regeneration.
Key Research Highlights
⚡ Ipamorelin
Classified as a selective growth hormone–releasing peptide (GHRP).
Targets the ghrelin receptor (GHSR) to stimulate GH release without significantly increasing cortisol or prolactin.
Commonly studied for potential effects on:
Demonstrates a clean, targeted GH release compared to earlier GHRPs.
🧬 CJC-1295 (Without DAC)
Modified Growth Hormone–Releasing Hormone (GHRH) analog designed to increase pituitary GH and IGF-1 levels naturally.
The “without DAC” (Drug Affinity Complex) version is short-acting, promoting natural pulsatile GH releaserather than continuous elevation.
Studied for roles in:
Fat loss and lean muscle growth
Improved recovery and repair processes
Enhanced sleep and overall metabolic balance
Synergistic Research Potential
The Ipamorelin + CJC-1295 (Without DAC) combination is among the most explored GH-axis research stacks due to their complementary mechanisms:
CJC-1295 initiates GH release signaling.
Ipamorelin amplifies and sustains the response.
Together, studies indicate improved GH pulsatility, IGF-1 expression, and tissue repair outcomes compared to single-agent use in preclinical settings.
Key research areas include:
Muscle and connective tissue recovery
Metabolic and lipid regulation
Sleep and cellular restoration
Anti-aging and longevity models
Molecular Details
Formulation: 5mg Ipamorelin + 5mg CJC-1295 (Without DAC) per vial
Appearance: Lyophilized powder for laboratory research use
Storage: Store lyophilized peptide at –20°C. Reconstituted solution should be refrigerated (2–8°C).
Solubility: Soluble in bacteriostatic water or sterile saline
⚠️ Disclaimer
This compound is for laboratory research use only.
Not for human consumption, medical, or veterinary purposes.
All Resilient Research Peptides products are tested for purity, identity, and consistency, ensuring high-quality results for scientific study.
This synergistic peptide blend pairs Ipamorelin, a selective growth hormone secretagogue, with CJC-1295 (without DAC), a potent GHRH analog. Together, they are widely researched for their ability to stimulate pulsatile growth hormone release and support studies focused on cellular recovery, metabolism, and tissue regeneration.
Key Research Highlights
⚡ Ipamorelin
Classified as a selective growth hormone–releasing peptide (GHRP).
Targets the ghrelin receptor (GHSR) to stimulate GH release without significantly increasing cortisol or prolactin.
Commonly studied for potential effects on:
Demonstrates a clean, targeted GH release compared to earlier GHRPs.
🧬 CJC-1295 (Without DAC)
Modified Growth Hormone–Releasing Hormone (GHRH) analog designed to increase pituitary GH and IGF-1 levels naturally.
The “without DAC” (Drug Affinity Complex) version is short-acting, promoting natural pulsatile GH releaserather than continuous elevation.
Studied for roles in:
Fat loss and lean muscle growth
Improved recovery and repair processes
Enhanced sleep and overall metabolic balance
Synergistic Research Potential
The Ipamorelin + CJC-1295 (Without DAC) combination is among the most explored GH-axis research stacks due to their complementary mechanisms:
CJC-1295 initiates GH release signaling.
Ipamorelin amplifies and sustains the response.
Together, studies indicate improved GH pulsatility, IGF-1 expression, and tissue repair outcomes compared to single-agent use in preclinical settings.
Key research areas include:
Muscle and connective tissue recovery
Metabolic and lipid regulation
Sleep and cellular restoration
Anti-aging and longevity models
Molecular Details
Formulation: 5mg Ipamorelin + 5mg CJC-1295 (Without DAC) per vial
Appearance: Lyophilized powder for laboratory research use
Storage: Store lyophilized peptide at –20°C. Reconstituted solution should be refrigerated (2–8°C).
Solubility: Soluble in bacteriostatic water or sterile saline
⚠️ Disclaimer
This compound is for laboratory research use only.
Not for human consumption, medical, or veterinary purposes.
All Resilient Research Peptides products are tested for purity, identity, and consistency, ensuring high-quality results for scientific study.
Image 1 of 1
